Effects of perhexiline on coronary hemodynamic and myocardial metabolic responses to tachycardia.
D000328:Adult; D000787:Angina Pectoris / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D001783:Blood Flow Velocity; D001794:Blood Pressure / Q000187:drug effects; D002302:Cardiac Output / Q000187:drug effects; D003326:Coronary Circulation / Q000187:drug effects*; D003331:Coronary Vessels / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D007773:Lactates / Q000378:metabolism; D008875:Middle Aged; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption / Q000187:drug effects; D010138:Pacemaker, Artificial; D010480:Perhexiline / Q000627:therapeutic use; D010880:Piperidines / Q000627:therapeutic use*; D013610:Tachycardia / Q000150:complications*; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D007773:Lactates; D010880:Piperidines; D014665:Vasodilator Agents; D010480:Perhexiline